Description
AGI-6780 is an inhibitor of isocitrate dehydrogenase (IDH) that displays anticancer activity. This compound induces differentiation in acute myeloid leukemia (AML) and TF-1 erythroleukemia cells.
Product Unit Size | Cost | Quantity | Stock |
---|
AGI-6780 is an inhibitor of isocitrate dehydrogenase (IDH) that displays anticancer activity. This compound induces differentiation in acute myeloid leukemia (AML) and TF-1 erythroleukemia cells.
Cas No. | 1432660-47-3 |
---|---|
Purity | ≥98% |
Formula | C21H18F3N3O3S2 |
Formula Wt. | 481.51 |
IUPAC Name | N-Cyclopropyl-4-(3-thienyl)-3-({[3-(trifluoromethyl)phenyl]carbamoyl}amino)benzenesulfonamide |
Synonym | AGI 6780, AGI6780 |
Solubility | DMSO 96 mg/mL (199.37 mM) Ethanol 96 mg/mL (199.37 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Lee WY, Chen KC, Chen HY, et al. Potential mitochondrial isocitrate dehydrogenase R140Q mutant inhibitor from traditional Chinese medicine against cancers. Biomed Res Int. 2014;2014:364625. PMID: 24995286.
Wang F, Travins J, DeLaBarre B, et al. Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation. Science. 2013 May 3;340(6132):622-6. PMID: 23558173.
Endogenous cardiomodulatory peptide; NPR-A agon...
α1-adrenergic antagonist.
KRAS inhibitor
AChE inhibitor, D2 antagonist.
Synthetic ITC.
Amino acid precursor of dopamine.
α2-adrenergic and imidazoline-1 antagonist, AT...
Endogenous peptide hormone inolved in gastric e...
Antifungal agent with neuroprotective activity....
Triterpenoid
Endogenous catecholamine precursor, also found ...
Mixture of taxanes.
Semi-synthetic avermectin; GABA potentiator.
Imidazoline derivative; α1-adrenergic agonist,...
mTOR inhibitor.
Protease inhibitor.
CB1 inverse agonist.
Kavalactone originally found in Piper methystic...
Polyanionic sulfated glycosaminoglycan, endogen...
Phase II enzyme inducer; Nrf2 activator; antiox...